Interestingly, AstraZeneca was largely silent much of the week, but by Friday, was forced to reply to a few blogs, including Pharmalot, after it became clear the affair would not simply go away as quickly as a newsletter could be tossed in the trash. (For earlier posts, scroll down or click on 'AstraZeneca' on the tags along the lower right for this past week's collection).

"Like it or not. Blogs, whether run by whistleblowers, marketers, patients or journalists, are a new front. And there's no going back."

Next week is likely to be still busier. Here's why:

Monday: Eli Lilly reports earnings;

Tuesday: House Energy and Commerce committee PDUFA hearing;

Wednesday: Senate Health Education Labor and Pensions committee PDUFA hearing;

Thursday: Merck, Schering-Plough and Wyeth report earnings;

Friday: Pfizer reports earnings.


Post a Comment

Google Analytics Alternative